NextPlat (NASDAQ:NXPL – Get Free Report) posted its earnings results on Thursday. The company reported ($0.28) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.46) by $0.18, Zacks reports. NextPlat had a negative return on equity of 54.66% and a negative net margin of 20.38%.
Here are the key takeaways from NextPlat’s conference call:
- Profitability improved substantially year over year: Gross margin rose to 35% from nearly 20%, while operating loss narrowed to $0.8 million from $2.2 million. Revenue fell to $10.5 million from $13.8 million, but healthcare operations recorded positive operating income.
- Higher-margin 340B contract services grew sharply: Healthcare contract revenue increased to $2.4 million from $0.6 million a year earlier, as new clients came online. Management said recently added contracts are still onboarding and could contribute further growth into early 2027.
- Retail pharmacy faced continuing volume and reimbursement pressure: Prescription revenue was down year over year amid lower payer reimbursements, payer-mix changes, and reduced volumes. The closure of a customer facility also hurt sequential results and margins.
- E-commerce remained a source of growth and diversification: Revenue rose 3% year over year, and the company reported record high-margin recurring airtime revenue, with sales reaching customers in more than 115 countries. New sales channels include Decathlon in 20 countries, though e-commerce revenue declined 6% sequentially due largely to seasonality.
- Management expects the Scott’s Pharmacy acquisition to add to results: The company said the Pensacola pharmacy is performing ahead of margin expectations and forecast about $1.2 million in fourth-quarter revenue and $150,000 in net profit at current activity levels. The all-cash purchase cost $1.5 million.
NextPlat Stock Down 18.7%
NextPlat stock traded down $1.55 during mid-day trading on Thursday, hitting $6.74. The company’s stock had a trading volume of 48,273 shares, compared to its average volume of 58,911. NextPlat has a 52-week low of $3.38 and a 52-week high of $9.94. The company has a market cap of $18.29 million, a PE ratio of -1.84 and a beta of 1.95. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.29 and a quick ratio of 1.92. The firm’s 50 day moving average is $8.86 and its 200 day moving average is $6.88.
Analyst Upgrades and Downgrades
NXPL has been the topic of several research analyst reports. Wall Street Zen raised shares of NextPlat to a “hold” rating in a research note on Saturday, August 22nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of NextPlat in a report on Wednesday, November 4th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $11.00.
View Our Latest Stock Analysis on NXPL
NextPlat Company Profile
NextPlat Corp. (NASDAQ: NXPL) is a technology-focused company operating in the e-commerce and healthcare sectors. The company develops and manages online commerce businesses, including the sale of consumer products through major digital marketplaces and direct-to-consumer channels. Through its e-commerce operations, NextPlat provides online retail, marketplace management, and related digital commerce services designed to help brands market and distribute products across platforms such as Amazon, Walmart, eBay, and Shopify.
See Also
- Five stocks we like better than NextPlat
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
- Midterm Fallout, NVIDIA Turmoil, Anthropic’s IPO: Is Broadcom a Steal?
- 3 Pharmaceutical Stocks That Offer Safety and Growth
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.
